CG Oncology, Inc.
CGON · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Kalofonos Isabel: Form 4
Insider disclosure · Filed · Report period 15 Oct 2026
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- CGON · 156944100 - Common Stock, par value $0.0001
Company details and SEC sources
CIK 0001991792 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CGON on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 3000 Pegasus Park Drive, Suite 1640, Dallas, TX, 75247
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields